The number of intellectual property applications for biotechnology discoveries submitted by researchers, institutes, and organisations backed by the Department of Biotechnology (DBT) is known as Patents Filed. Medical biotechnology, agricultural biotechnology, bioinformatics, industrial biotech processes, and environmental technologies are just a few of the many fields that are covered by these patents. Protecting inventions, promoting innovation, and promoting the commercialisation of research findings produced under DBT-supported initiatives all depend on the filing of patents. The relevance of patents filed under DBT lies in their role in promoting research and development, protecting intellectual property, and enhancing India’s global competitiveness in biotechnology. Patents reflect the originality and applicability of scientific discoveries, incentivizing both public and private institutions to innovate. They also facilitate technology transfer, collaborations with industry, and commercialization, leading to new products, services, and solutions that benefit society. Furthermore, tracking patents helps policymakers evaluate the impact of funded research, identify areas of emerging expertise, and strengthen India’s position as a hub for biotechnology innovation. Overall, patents filed under DBT are a key indicator of scientific productivity, innovation capacity, and the nation’s progress in the knowledge-based economy.